Skip to content

Pilot Study of BAO-G Technique in TAAA Endovascular Repair

Pilot Study of Multi-Branch AOrtic Reconstruction With G-iliac System (BAO-G) Technique in Thoracoabdominal Aortic Aneurysm Endovascular Repair

Status
Enrolling by invitation
Phases
Early Phase 1
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT06534281
Enrollment
20
Registered
2024-08-02
Start date
2022-01-01
Completion date
2035-12-31
Last updated
2024-08-02

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Aortic Aneurysm, Thoracoabdominal

Keywords

BAO-G technique, thoracoabdominal aortic aneurysm, iliac-branched devices, endovascular repair

Brief summary

Multi-Branch AOrtic Reconstruction With G-iliac System (BAO-G) Technique is a novel technique of endovascular repair of thoracoabdominal aortic aneurysm, which using off-the-shelf iliac branched devices to reconstruct the visceral branches. This study aims to evaluate the safety and efficacy of BAO-G in thoracoabdominal aortic aneurysm endovascular repair.

Interventions

PROCEDUREBAO-G

Using G-iliac system to reconstruct the visceral branches of in endovascular repair of thoracoabdominal aortic aneurysm.

Sponsors

Peking Union Medical College Hospital
Lead SponsorOTHER

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
TREATMENT
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to 80 Years
Healthy volunteers
No

Inclusion criteria

1. Patients with TAAA, confirmed by aortic CTA. 2. TAAA diameter ≥ 6cm, or symptomatic TAAA with diameter ≥ 4cm. 3. Informed consent signed.

Exclusion criteria

1. were pregnant. 2. had a history of previous endovascular or open repair. 3. had other contraindications of endovascular treatment. 4. Uncontrolled autoimmune disease.

Design outcomes

Primary

MeasureTime frameDescription
Rate of visceral branch patencyMonth 0, 3, 6, 12, and annually after surgerythe patency of visceral branches measured by radiological test
Incidence of endoleakMonth 0, 3, 6, 12, and annually after surgeryThe incidence of endoleak measured by radiological test
Incidence of re-operationMonth 0, 3, 6, 12, and annually after surgeryThe incidence of re-operation for any adverse events, confirmed by medical record and outpatient follow up

Secondary

MeasureTime frameDescription
Incidence of organ ischemiaMonth 0, 3, 6, 12, and annually after surgeryIncidence of organ ischemia, measured by physical examination and radiological test
Incidence of acute pancreatitisperioperative periodThe incidence of acute pancreatitis, measured by serum amylase level
Incidence of acute kidney injuryperioperative periodThe incidence of acute kidney injury, measured by serum creatinine level
Incidence of acute liver function injuryperioperative periodThe incidence of acute liver function injury, measured by serum transaminase level

Countries

China

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026